Status:

COMPLETED

Role of Proteomics in Diagnosing Sarcoidosis

Lead Sponsor:

Maastricht University Medical Center

Conditions:

Sarcoidosis

Eligibility:

All Genders

18-70 years

Brief Summary

Sarcoidosis is a multi-systemic disorder, meaning that it can involve any organ in the body and that its clinical presentation is highly variable. In 90% of all sarcoidosis cases the lungs are affecte...

Eligibility Criteria

Inclusion

  • Clinical diagnosis of pulmonary sarcoidosis stage I-IV

Exclusion

  • Non-smoking
  • No treatment for extra-pulmonary symptoms of sarcoidosis

Key Trial Info

Start Date :

March 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 1 2012

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT00626938

Start Date

March 1 2005

End Date

March 1 2012

Last Update

November 7 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Maastricht University Medical Centre

Maastricht, Netherlands, 6202 AZ

Role of Proteomics in Diagnosing Sarcoidosis | DecenTrialz